324 related articles for article (PubMed ID: 17913342)
1. Somatostatin/somatostatin receptor signalling: phosphotyrosine phosphatases.
Florio T
Mol Cell Endocrinol; 2008 May; 286(1-2):40-8. PubMed ID: 17913342
[TBL] [Abstract][Full Text] [Related]
2. The phosphotyrosine phosphatase eta mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2.
Massa A; Barbieri F; Aiello C; Iuliano R; Arena S; Pattarozzi A; Corsaro A; Villa V; Fusco A; Zona G; Spaziante R; Schettini G; Florio T
Ann N Y Acad Sci; 2004 Dec; 1030():264-74. PubMed ID: 15659806
[TBL] [Abstract][Full Text] [Related]
3. [The activation of the phosphotyrosine phosphatase eta is responsible for the somatostatin inhibition of PCCl3 thyroid cell proliferation].
Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Villa V; Pattarozzi A; Diana F; Fusco A; Schettini G
Minerva Endocrinol; 2001 Dec; 26(4):277-83. PubMed ID: 11782716
[TBL] [Abstract][Full Text] [Related]
4. Biology of somatostatin in breast cancer.
Watt HL; Kharmate G; Kumar U
Mol Cell Endocrinol; 2008 May; 286(1-2):251-61. PubMed ID: 18308465
[TBL] [Abstract][Full Text] [Related]
5. Neuronal nitric oxide synthase: a substrate for SHP-1 involved in sst2 somatostatin receptor growth inhibitory signaling.
Lopez F; Ferjoux G; Cordelier P; Saint-Laurent N; Estève JP; Vaysse N; Buscail L; Susini C
FASEB J; 2001 Oct; 15(12):2300-2. PubMed ID: 11511520
[TBL] [Abstract][Full Text] [Related]
6. An intracellular multi-effector complex mediates somatostatin receptor 1 activation of phospho-tyrosine phosphatase eta.
Arena S; Pattarozzi A; Massa A; Esteve JP; Iuliano R; Fusco A; Susini C; Florio T
Mol Endocrinol; 2007 Jan; 21(1):229-46. PubMed ID: 17021051
[TBL] [Abstract][Full Text] [Related]
7. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation.
Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Pattarozzi A; Bajetto A; Trapasso F; Fusco A; Schettini G
Mol Endocrinol; 2001 Oct; 15(10):1838-52. PubMed ID: 11579215
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine phosphatases in osteoclast differentiation, adhesion, and bone resorption.
Granot-Attas S; Elson A
Eur J Cell Biol; 2008 Sep; 87(8-9):479-90. PubMed ID: 18342392
[TBL] [Abstract][Full Text] [Related]
9. SHP protein tyrosine phosphatase expression in rat uterine tissue.
Phillippe M; Bradley DF; Engle D; Sweet L
J Soc Gynecol Investig; 2006 Jul; 13(5):338-42. PubMed ID: 16814162
[TBL] [Abstract][Full Text] [Related]
10. A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail.
Poole AW; Jones ML
Cell Signal; 2005 Nov; 17(11):1323-32. PubMed ID: 16084691
[TBL] [Abstract][Full Text] [Related]
11. Ligands and signaling through receptor-type tyrosine phosphatases.
Bixby JL
IUBMB Life; 2001 Mar; 51(3):157-63. PubMed ID: 11547917
[TBL] [Abstract][Full Text] [Related]
12. Oxidation sensitivity of the catalytic cysteine of the protein-tyrosine phosphatases SHP-1 and SHP-2.
Weibrecht I; Böhmer SA; Dagnell M; Kappert K; Ostman A; Böhmer FD
Free Radic Biol Med; 2007 Jul; 43(1):100-10. PubMed ID: 17561098
[TBL] [Abstract][Full Text] [Related]
13. Novel signals mediating the functions of somatostatin: the emerging role of NO/cGMP.
Thermos K
Mol Cell Endocrinol; 2008 May; 286(1-2):49-57. PubMed ID: 18384933
[TBL] [Abstract][Full Text] [Related]
14. Yeast substrate-trapping system for isolating substrates of protein tyrosine phosphatases: Isolation of substrates for protein tyrosine phosphatase receptor type z.
Fukada M; Kawachi H; Fujikawa A; Noda M
Methods; 2005 Jan; 35(1):54-63. PubMed ID: 15588986
[TBL] [Abstract][Full Text] [Related]
15. Analyzing protein tyrosine phosphatases by phosphotyrosine analog integration.
Shen K
Methods; 2007 Jul; 42(3):234-42. PubMed ID: 17532510
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: a primary role for tyrosine phosphatase SHP-1.
Douziech N; Calvo E; Coulombe Z; Muradia G; Bastien J; Aubin RA; Lajas A; Morisset J
Endocrinology; 1999 Feb; 140(2):765-77. PubMed ID: 9927304
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor 1 (SSTR1)-mediated inhibition of cell proliferation correlates with the activation of the MAP kinase cascade: role of the phosphotyrosine phosphatase SHP-2.
Florio T; Thellung S; Arena S; Corsaro A; Bajetto A; Schettini G; Stork PJ
J Physiol Paris; 2000; 94(3-4):239-50. PubMed ID: 11088001
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells.
Watt HL; Kharmate GD; Kumar U
Cell Signal; 2009 Mar; 21(3):428-39. PubMed ID: 19070659
[TBL] [Abstract][Full Text] [Related]
19. Potential indications for somatostatin analogues: immune system and limphoproliferative disorders.
Ferone D; Resmini E; Boschetti M; Arvigo M; Albanese V; Ceresola E; Pivonello R; Albertelli M; Bianchi F; Giusti M; Minuto F
J Endocrinol Invest; 2005; 28(11 Suppl International):111-7. PubMed ID: 16625859
[TBL] [Abstract][Full Text] [Related]
20. Protein tyrosine phosphatases and breast cancer.
Freiss G; Vignon F
Crit Rev Oncol Hematol; 2004 Oct; 52(1):9-17. PubMed ID: 15363463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
